Sarcoidosis is not caused by a single, identifiable trigger. It develops when a person with a genetic predisposition encounters something, likely an environmental substance or a common bacterium, that sets off an exaggerated immune response. The immune system overreacts by forming tiny clusters of inflammatory cells called granulomas, most often in the lungs and lymph nodes but potentially in the skin, eyes, heart, or nearly any organ. Sarcoidosis is not contagious and cannot be passed from person to person.
The Immune Response Behind Sarcoidosis
A granuloma is essentially an organized ball of immune cells. When your immune system detects something it perceives as a threat, white blood cells called macrophages rush to the site. Normally, macrophages destroy the foreign material and the response winds down. In sarcoidosis, those macrophages don’t stand down. Instead, they transform into specialized cells, fuse together, and recruit more immune cells to form a dense, persistent structure.
A key part of the problem is that the macrophages begin proliferating instead of dying off the way they normally would. Signals inside these cells shift their metabolism and block the usual self-destruct process, keeping the granuloma alive indefinitely. Meanwhile, a type of immune cell called CD4+ T cells floods the affected tissue, driving a cycle of inflammation dominated by a strong “attack mode” immune profile. These T cells release chemical signals that recruit still more immune cells, reinforcing the granuloma and potentially damaging the surrounding tissue over time.
This is why sarcoidosis can be so unpredictable. The granulomas may resolve on their own, or they may persist for years and eventually cause scarring (fibrosis) in the affected organ.
Genetic Predisposition
Your genes play a significant role in whether your immune system is prone to this kind of overreaction. Specific variations in immune-system genes, particularly those that help your body distinguish foreign material from your own tissue, have been linked to sarcoidosis risk. One well-studied variant, a gene called HLA-DRB1*1101, carries a population-level risk of about 16% in Black Americans and 9% in white Americans. Other gene variants appear to influence not just whether you develop sarcoidosis but which organs it affects: some are associated with eye involvement, others with bone marrow disease or calcium imbalances.
Sarcoidosis clusters in families. First-degree relatives of someone with sarcoidosis have a notably higher prevalence of the disease, and familial clustering is especially prominent among African Americans. Having the genetic predisposition alone, however, is not enough. Most people who carry these gene variants never develop sarcoidosis. Something in the environment has to pull the trigger.
Environmental and Occupational Triggers
Researchers have identified a growing list of environmental exposures that appear to provoke sarcoidosis in susceptible people. Inhaled inorganic particles are among the strongest suspects. Silica dust, metal dusts (including beryllium, aluminum, cobalt, nickel, and iron), mold, mildew, pesticides, and wood dust have all been linked to the disease. After the September 11 attacks, elevated rates of sarcoidosis among first responders exposed to World Trade Center dust provided striking real-world evidence of this connection.
Certain occupations carry higher risk because of what workers breathe in day after day. Firefighters, nurses, and military personnel all show increased incidence. Jobs with heavy exposure to crystalline silica, such as mining, quarrying, stonemasonry, construction, foundry work, and brick and tile manufacturing, are considered particularly high risk. Agricultural workers exposed to pesticides, cotton dust, or bird-related materials also face elevated odds. Welders, who inhale metal fumes regularly, are another group that appears more vulnerable.
This doesn’t mean everyone in these professions will develop sarcoidosis. It means that chronic exposure to certain airborne particles can act as the environmental trigger in people whose genetics have already loaded the gun.
The Bacterial Connection
One of the more compelling lines of research points to a common skin bacterium, Propionibacterium acnes (the same organism involved in acne), as a potential trigger. P. acnes is the only microorganism that has been directly cultured from sarcoid lesions, and its genetic material shows up at high frequency and concentration in the lymph nodes of sarcoidosis patients across both Japanese and European populations.
Here’s what makes P. acnes especially interesting: it is one of the most common bacteria living quietly in healthy human lungs and lymph nodes. Most people tolerate it without issue. But in sarcoidosis patients, a specific protein produced by the bacterium, called trigger factor, provokes an aggressive immune response that doesn’t occur in people without the disease. In animal studies, mice sensitized to this protein developed lung granulomas, but only if they already harbored a latent P. acnes infection. When antibiotics eradicated the bacteria beforehand, no granulomas formed.
The working theory is that in genetically susceptible individuals, something causes this otherwise harmless resident bacterium to multiply inside cells. The immune system then overreacts, forming granulomas to wall off the threat. If the bacteria escape that containment, they can spread to other organs, which may explain how sarcoidosis sometimes appears in multiple body systems at once.
Mycobacteria, the family of bacteria that causes tuberculosis, have also been investigated as potential triggers. Fragments of mycobacterial DNA have been found in some sarcoidosis tissue samples, though the evidence is less consistent than for P. acnes.
Who Is Most at Risk
Sarcoidosis peaks before age 40 and shows strong patterns by race and sex. The two populations most affected are African Americans and Northern Europeans. In the United States, Black patients develop sarcoidosis more frequently, experience higher mortality, and tend to be affected at younger ages compared to white patients. Age-adjusted mortality rates are also higher in women than in men across racial groups.
Beyond demographics, risk increases if you have a family history of the disease, work in one of the high-exposure occupations described above, or live in an environment with heavy exposure to mold, dust, or certain chemicals. Smoking, interestingly, has not been established as a risk factor and some data suggest it may even be inversely associated with the disease, though that finding remains debated.
Why the Cause Still Isn’t Fully Understood
The prevailing model is that sarcoidosis requires a collision of factors: the right (or wrong) genetic makeup, exposure to a triggering substance, and an immune system that responds with excessive, sustained inflammation rather than a proportionate defense. No single antigen or exposure has been identified as “the” cause, and it is entirely possible that different triggers cause sarcoidosis in different people. One patient’s disease might be driven by silica exposure at a construction site, while another’s might stem from an immune overreaction to bacteria already living in their lungs.
This complexity is part of what makes sarcoidosis so difficult to predict, prevent, or cure. It is not an infection you can catch, not a purely genetic condition you inherit in a straightforward way, and not simply an occupational disease. It sits at the intersection of all three, which is why researchers describe it as an antigen-driven immune response in genetically predisposed individuals, triggered by exposures that remain, in many individual cases, unidentified.